To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Leukocyte-poor PRP effective and safe versus placebo for symptomatic knee OA treatment

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
July 2016

Leukocyte-poor PRP effective and safe versus placebo for symptomatic knee OA treatment

Vol: 5| Issue: 7| Number:34| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Intra-articular Autologous Conditioned Plasma Injections Provide Safe and Efficacious Treatment for Knee Osteoarthritis: An FDA-Sanctioned, Randomized, Double-blind, Placebo-controlled Clinical Trial

Am J Sports Med. 2016 Apr;44(4):884-91

Contributing Authors:
PA Smith

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

30 patients with Kellgren-Lawrence grade II-III knee osteoarthritis were randomized to receive three weekly intra-articular injections of either leukocyte-poor platelet rich plasma (LP-PRP) autologous conditioned plasma or placebo saline. The purpose of this study was to determine if LP-PRP administration demonstrated efficacy for improvement in pain, stiffness, and function on the Western Ontario...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue